Skip to content

Based on the theory of inflammatory factors to explore the clinical study of Jianpi method in the treatment of cancer-related fatigue combined with nutritional risk in patients with colorectal cancer

Based on the theory of inflammatory factors to explore the clinical study of strengthening spleen in the treatment of cancer-related fatigue combined with nutritional risk in patients with colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000031
Enrollment
Unknown
Registered
2024-03-17
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Nutrition based treatment group:NA
Nutrition+Practice training Group:Practice training
Nutrition+Traditional Chinese Medicine Group:Traditional Chinese Medicine

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.The pathological diagnosis is confirmed to be a patient with postoperative stage II-III colorectal cancer, and chemotherapy has been completed for 1-2 months; 2.Age: 18-75 years old; 3.Patients diagnosed with spleen deficiency syndrome in traditional Chinese medicine; 4.Patients diagnosed with cancer-related fatigue; 5.Nutritional risk assessment for individuals with nutritional risks; 6.Individuals with a physical condition ECOG score = 2 points; 7.Individuals without strict focus, liver, kidney, hematopoietic system disorders, or other factors affecting drug evaluation; 8.Voluntarily participate and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those who do not meet the inclusion criteria; 2.Individuals with obvious impairment of heart, liver, kidney, or hematopoietic function; 3.Previous or concurrent history of other malignant tumors; 4.Existence of severe respiratory, urinary, cardiovascular, rheumatic and immune, neurological, and metabolic underlying diseases, as well as severe digestive system diseases other than intestinal diseases; 5.Patients with allergies to known components of traditional Chinese medicine used in the study; 6.Pregnant women, lactating women, and patients with mental illness; 7.Participate in other clinical researchers.

Design outcomes

Primary

MeasureTime frame
Serum inflammatory factors;Fatigue Score (Piper Fatigue Scale);

Secondary

MeasureTime frame
Nutritional indicators;QLQ-C30 Quality of Life Scale;Traditional Chinese Medicine Symptom Score;PG-SGA Nutritional Assessment Scale;

Countries

China

Contacts

Public ContactYuelei Cheng

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

chyuelei@126.com13918412017

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026